Fierce Pharma

JANUARY 24, 2024

The FDA’s letter demanding a labeling change for Gilead Sciences’ Tecartus temporarily went missing on the agency’s website Tuesday. | The FDA’s letter demanding a labeling change for Gilead Sciences’ Tecartus temporarily went missing on the agency’s website Tuesday. Turns out, the FDA didn’t drop the CD19 CAR-T from a classwide safety alert list. Instead, it's adjusted the wording of a proposed boxed warning.

Safety 261

Safety FDA 261

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. AI/ML is predicted to be the top technology investment for 60 percent of life sciences companies over the next two years, according to a recent survey 1 from the Pistoia Alliance.

Pharma 130

Pharma Pharmaceutical manufacturing Manufacturing Pharmaceutical 130

Fierce Pharma

JANUARY 24, 2024

It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgoci | It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgocitinib to treat atopic dermatitis. Slowly but surely, Denmark’s Leo Pharma—which gained the rights to develop and commercialize delgocitinib in the rest of the world a decade ago—is working toward its first green light for the topical cream.

Pharma 228

Pharma Patients 228

pharmaphorum

JANUARY 24, 2024

CG Oncology completes the first biotech IPO of 2024, raising $380 million for its oncolytic virus bladder cancer immunotherapy.

132

132

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 24, 2024

Another prostate cancer trial has hit its main goal, and yet the drug developer can’t immediately file for an FDA approval. | In a similar pattern as Novartis' radiotherapy Pluvicto, Exelixis now has positive prostate cancer data for a combination of Cabometyx and Roche's Tecentriq, and yet the drug developer can't immediately file for an FDA approval.

FDA 184

FDA 184

MedCity News

JANUARY 24, 2024

After experiencing firsthand the shortcomings of existing public and private programs to treat children’s developmental delays, Jen Wirt founded a startup called Coral Care. The company, which announced its official launch on Tuesday, brings pediatric developmental specialty care into families’ homes.

112

112

MedCity News

JANUARY 24, 2024

Eli Lilly said its experimental gene therapy restored hearing in a boy born with profound hearing loss. The results for this experimental treatment come three months after Regeneron Pharmaceuticals reported early but encouraging data for its hearing loss gene therapy.

Pharmaceutical 111

Pharmaceutical Biopharma Pharma 111

Fierce Pharma

JANUARY 24, 2024

Over the years, myriad generic drugmakers have had to ante up fines and settlement fees for allegedly colluding on the prices of copycat drugs. | Apotex and two of its generics peers have agreed to settle with direct purchasers of their drugs in a price-fixing case that stretches all the way back to 2017.

187

187

MedCity News

JANUARY 24, 2024

By partnering with a cloud managed service provider, one can overcome cloud staffing and security issues and better align internal resources with the things that make your business special, like developing new apps and features that enhance healthcare services and improve health outcomes for end users.

Management 106

Management Healthcare Healthcare Specialization 106

Fierce Pharma

JANUARY 24, 2024

Dangerously low levels of blood sugar—attributed to counterfeit versions of Novo Nordisk’s Ozempic—hospitalized three people in the United States last year, the American Association of Poison Contr | Dangerously low levels of blood sugar—attributed to potentially counterfeit versions of Novo Nordisk’s Ozempic—hospitalized three people in the United States last year, the American Association of Poison Control Centers (AAPCC) told Reuters.

172

172

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTech

JANUARY 24, 2024

Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.

Biopharma 98

Biopharma Manufacturing 98

MedCity News

JANUARY 24, 2024

Virtual reality reduces the cost of training while also improving learning efficiency and knowledge retention. It’s not just universities and medical students that are embracing VR technology for learning. I travel all over the world to work with healthcare teams implementing VR and have observed, that a growing number of hospitals are using it for continuing education.

Healthcare 107

Healthcare Healthcare Education Training 107

PharmaVoice

JANUARY 24, 2024

Executives on the healthcare giant’s full-year earnings call highlighted a strong cash position and incremental dealmaking as a way to get past incoming competition.

Competition 98

Competition Healthcare Healthcare 98

MedCity News

JANUARY 24, 2024

Cherish Health recently launched Cherish Serenity, a device that sits in the home and can detect falls across multiple rooms. If there is an emergency, it will notify a caregiver or response center for help.

Safety 105

Safety 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 24, 2024

LEO Pharma's chronic hand eczema drug delgocitinib has outperformed the only approved drug for the condition in a phase 3 trial.

Pharma 109

Pharma 109

MedCity News

JANUARY 24, 2024

In 61% of counties with a PCP shortage, there is a high volume of retail pharmacies. It reveals an opportunity for pharmacists, who have the education and training, and are already providing vaccinations, tests and frontline treatments to amplify the impact they can have on providing accessible care in the communities they serve.

Retail 98

Retail Education Training Physicians 98

Pharmaceutical Technology

JANUARY 24, 2024

Accent Therapeutics has raised $75m in a Series C financing round to progress the development of precision cancer therapies.

109

109

pharmaphorum

JANUARY 24, 2024

BenevolentAI’s search for a new chief executive has concluded with the appointment of industry bigwig Dr Jörg Möller to the role, four months after Joanna Shields stepped down and as the company emerges from a restructuring drive. The UK artificial intelligence specialist said in a statement that Möller is “an accomplished R&D leader and champion of the application of AI to drug discovery.

Pharma 94

Pharma 94

Advertisement

Pharmaceutical Technology

JANUARY 24, 2024

The company could be in line for a priority review voucher if 4D-710, currently in Phase I/II clinical trials, is approved.

104

104

pharmaphorum

JANUARY 24, 2024

BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.

100

100

Pharmaceutical Commerce

JANUARY 24, 2024

Dave DeJean provides his expert insight on lessons he’s learned from his plethora of time in the industry, along with an outlook on where the pharma supply chain stands in adhering to the Drug Supply Chain Security Act (DSCSA).

Pharma 64

Pharma 64

pharmaphorum

JANUARY 24, 2024

A consortium led by the Digital Medicine Society (DiMe) has been formed to tackle a thorny problem for digital health product (DHP) developers – how to bring them to market in a way that ensures they are commercially sustainable.

Medicine 69

Medicine Marketing 69

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

JANUARY 24, 2024

Patients living with sickle cell disease and thalassaemia will be eligible for the test

Patients 87

Patients 87

PharmaVoice

JANUARY 24, 2024

The most studied diseases last year included three types of cancer as research into COVID-19 fell sharply in the post-pandemic era.

65

65

PharmaTimes

JANUARY 24, 2024

The new company will develop novel therapies to benefit the body’s immune system

Pharma 86

Pharma 86

Scott’s Directories

JANUARY 24, 2024

Manitoba’s healthcare system is experiencing a growing population coupled with an aging demographic. Effective management and planning hinge on informed decision-making powered by robust data insights. Here, the Manitoba physician directory from MD Select emerges as an indispensable tool, offering unprecedented access to comprehensive data crucial for accurately forecasting physician demands.

Physicians 52

Physicians Distribution Doctors Recruitment 52

Advertisement

Distribution

Pharmaceutical Commerce

JANUARY 24, 2024

Treatments required to have updated warnings include all FDA-approved CAR T-cell therapies and licensed BCMA-directed and CD19-directed genetically modified autologous CAR T-cell immunotherapies.

FDA 52

FDA 52

European Pharmaceutical Review

JANUARY 24, 2024

Sanofi has agreed to acquire Inhibrx, Inc. for approximately $1.7 billion, therefore taking on a potential best-in-class treatment for rare lung and liver disease alpha-1 antitrypsin deficiency (AATD). A promising best-in-class rare disease treatment AATD is an inherited rare disease of the lungs and liver, which according to Sanofi, is characterised by low levels of AAT protein, a neutrophil elastase inhibitor.

Safety 52

Safety Patients Pharmaceutical 52

PharmExec

JANUARY 24, 2024

Under the agreement, Bristol Myers Squibb obtains Mirati’s entire portfolio, including Krazati (adagrasib) for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer.

52

52

Pharmaceutical Commerce

JANUARY 24, 2024

The definitive merger agreement was reached in October 2023, with Bristol Myers Squibb acquiring Mirati for $58 per share in cash, for a total equity value of $4.8 billion.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales